OnKure Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from OnKure Therapeutics Inc
Access all reports
Reneo Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on developing therapies for patients with rare genetic mitochondrial diseases. These diseases often involve the mitochondria's inability to efficiently produce energy for cells, impacting various bodily functions. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.
Key slides for OnKure Therapeutics Inc
Corporate Presentation
OnKure Therapeutics Inc
Corporate Presentation
OnKure Therapeutics Inc
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
OKUR
Country
🇺🇸 United States